These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2769972)

  • 1. [Factor V inhibitor with double cancer].
    Okajima A; Horii J; Nasu K; Niki Y; Akasaka K; Yamashita H; Sugimoto M; Yoshioka A
    Rinsho Ketsueki; 1989 Apr; 30(4):514-9. PubMed ID: 2769972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].
    Takaku T; Kuriyama Y; Shoji N; Otawa M; Gotoh A; Miyazawa K; Fukutake K; Ohyashiki K
    Rinsho Ketsueki; 2002 Dec; 43(12):1050-4. PubMed ID: 12607994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A long-lasting idiopathic factor V inhibitor].
    Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical cases of acquired coagulation inhibitors].
    Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
    Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case positive for the inhibitor for coagulation factor V].
    Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
    Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired inhibitor against coagulation factor V with severe hematuria].
    Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
    Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
    Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
    Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V inhibitor associated with immune complex formation.
    Lazarchick J; Wolff CM; Pepkowitz SH; Kizer J; Romein LA
    Arch Pathol Lab Med; 1986 May; 110(5):448-51. PubMed ID: 3754431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anesthetic management of a patient with acquired factor V inhibitor].
    Nakamura T; Otsuji M; Kurita A; Yamada K; Tsubokawa T; Yamamoto K
    Masui; 2010 Nov; 59(11):1423-7. PubMed ID: 21077315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
    Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
    Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An acquired factor V inhibitor: clinical and laboratory features.
    Shastri KA; Ho C; Logue G
    J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report.
    Denis A; Baudeau C; Verdy E; Couderc R; Rondeau E; Sraer JD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):165-9. PubMed ID: 7644356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
    Miesbach W; Voigt J; Peetz D; Scharrer I
    Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
    Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
    Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneously acquired haemophilia: report of a patient with prostatic adenoma].
    Barrier F; de La Guerenne A; Semjen E; Wierre L; Horrent S; Decaudin B; Resibois JP; Weillaert MP; Azar R; Odou P
    Ann Biol Clin (Paris); 2006; 64(4):347-52. PubMed ID: 16829479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy of an acquired factor V inhibitor.
    Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
    Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
    Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
    Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)].
    Lerolle D; Dreyer-Dufer C; Allain JP
    Nouv Presse Med; 1981 Apr; 10(18):1483-7. PubMed ID: 6789299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.